- Home
- BBIO vs DINO Comparison
BBIO vs DINO Comparison
Compare BBIO & DINO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBIO | DINO |
|---|---|---|
| Founded | 2015 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 12.9B |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BBIO | DINO |
|---|---|---|
| Price | $74.24 | $105.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 15 |
| Target Price | ★ $86.33 | $61.50 |
| AVG Volume (30 Days) | 1.9M | ★ 2.3M |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 3.03% |
| EPS Growth | N/A | ★ 238.46 |
| EPS | N/A | ★ 8.48 |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | $8.01 |
| Revenue Next Year | $73.78 | N/A |
| P/E Ratio | ★ N/A | $12.58 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $48.78 | $45.71 |
| 52 Week High | $93.42 | $108.25 |
Technical Indicators
Market Signals| Indicator | BBIO | DINO |
|---|---|---|
| Relative Strength Index (RSI) | 33.75 | 74.54 |
| Support Level | $70.65 | $47.04 |
| Resistance Level | $75.91 | N/A |
| Average True Range (ATR) | 2.16 | 3.68 |
| MACD | -0.80 | 0.94 |
| Stochastic Oscillator | 3.10 | 90.58 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About DINO HF Sinclair Corporation
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.